NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,610 | -5.8% | 6,576 | -3.3% | 0.00% | 0.0% |
| Q2 2023 | $50,539 | -9.7% | 6,802 | -15.8% | 0.00% | 0.0% |
| Q1 2023 | $55,967 | -34.7% | 8,076 | -3.1% | 0.00% | -50.0% |
| Q4 2022 | $85,674 | -74.0% | 8,334 | -54.0% | 0.00% | -71.4% |
| Q3 2022 | $330,000 | -65.9% | 18,123 | -3.7% | 0.01% | -61.1% |
| Q2 2022 | $968,000 | -47.3% | 18,812 | -24.6% | 0.02% | -35.7% |
| Q1 2022 | $1,837,000 | -45.8% | 24,936 | +5.2% | 0.03% | -41.7% |
| Q4 2021 | $3,391,000 | -26.5% | 23,703 | +6.5% | 0.05% | -31.4% |
| Q3 2021 | $4,613,000 | -1.1% | 22,250 | +1.3% | 0.07% | +1.4% |
| Q2 2021 | $4,663,000 | +27.2% | 21,963 | +8.7% | 0.07% | +21.1% |
| Q1 2021 | $3,665,000 | +119.6% | 20,214 | +35.0% | 0.06% | +103.6% |
| Q4 2020 | $1,669,000 | +57.2% | 14,968 | +52.8% | 0.03% | +40.0% |
| Q3 2020 | $1,062,000 | +142.5% | 9,799 | +86.3% | 0.02% | +122.2% |
| Q2 2020 | $438,000 | – | 5,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |